Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:11 pm Sale | 2021-12-31 | 13G | PlayAGS, Inc. AGS | Arrowpoint Asset Management LLC | 2,647,264 7.170% | -759,756 (-22.30%) | Filing History |
| 2022-02-14 2:09 pm Sale | 2021-12-31 | 13G | ACTUA CORP COM ACTA | Arrowpoint Asset Management LLC | 1,913,176 5.990% | -102,803 (-5.10%) | Filing History |
| 2022-01-10 4:04 pm Purchase | 2021-12-31 | 13G | ACV Auctions Inc. ACVA | Arrowpoint Asset Management LLC | 10,628,034 11.390% | 3,812,110 (+55.93%) | Filing History |
| 2021-12-10 4:09 pm Purchase | 2021-11-30 | 13G | ACV Auctions Inc. ACVA | Arrowpoint Asset Management LLC | 6,815,924 7.310% | 2,469,296 (+56.81%) | Filing History |
| 2021-10-13 06:01 am Sale | 2021-09-30 | 13G | Forte Biosciences, Inc. FBRX | Arrowpoint Asset Management LLC | 0 0.000% | -55,783 (Position Closed) | Filing History |
| 2021-08-10 4:07 pm Purchase | 2021-07-31 | 13G | ACV Auctions Inc. ACVA | Arrowpoint Asset Management LLC | 4,346,628 22.840% | 1,588,582 (+57.60%) | Filing History |
| 2021-07-12 3:52 pm Sale | 2021-06-30 | 13G | Sally Beauty Holdings, Inc. SBH | Arrowpoint Asset Management LLC | 14,974,701 13.260% | -5,723,191 (-27.65%) | Filing History |
| 2021-06-10 2:52 pm Purchase | 2021-05-31 | 13G | ACV Auctions Inc. ACVA | Arrowpoint Asset Management LLC | 2,758,046 14.490% | 2,758,046 (New Position) | Filing History |
| 2021-04-12 4:21 pm Purchase | 2021-03-31 | 13G | 2U, Inc. TWOU | Arrowpoint Asset Management LLC | 248,556 10.100% | 48,259 (+24.09%) | Filing History |
| 2021-04-12 4:20 pm Purchase | 2021-03-31 | 13G | Talis Biomedical Corporation TLIS | Arrowpoint Asset Management LLC | 398,319 23.300% | 190,632 (+91.79%) | Filing History |
| 2021-04-12 4:19 pm Purchase | 2021-03-31 | 13G | NexImmune, Inc. NEXI | Arrowpoint Asset Management LLC | 103,705 11.400% | 103,705 (New Position) | Filing History |
| 2021-04-12 4:17 pm Sale | 2021-03-31 | 13G | Forte Biosciences, Inc. FBRX | Arrowpoint Asset Management LLC | 55,783 10.320% | -61,686 (-52.51%) | Filing History |